Showing posts with label Stephen Harper. Show all posts
Showing posts with label Stephen Harper. Show all posts

Tuesday, April 03, 2007

Cipla launches 3-in-1 AIDS drug in India

Cipla has launched an innovative combination of 3 HIV/AIDS drugs, Viraday that needs to be taken just once a day for effective treatment.

The three anti-HIV drugs efavirenz 600 mg, tenofovir 300 mg and emtricitabine 200mg comprise the drug Viraday. Viraday, one tablet of which alone effectively treats a HIV infected person, eliminates the need for 3 separate medicines. This drug has some advantages like, it is less burdensome and it can be taken along with tuberculosis medicines, which could not be done previously.

This combination drug, that was previously available only in the U.S. and European countries, was first launched in India by Cipla on Thursday. In the U.S. and Europe this combination drug costs Rs. 52,800 a month, whereas Cipla will make it accessible at just Rs. 5,200 per month. This combination drug is less toxic than when the drugs are taken separately.

This breakthrough would improve the adherence-how faithfully patients stick to the course of treatment advised by the doctor. “This is a vital issue in HIV treatment to prevent the infection
from reaching the advanced stage of AIDS,” said senior consultant in Internal Medicine at Indraprastha Apollo Hospital, Dr Nalin Nag. He said, “Viraday is very patient friendly, as it requires just one pill a day and freedom from the severe side effect of many other anti HIV drugs.”

The innovative treatment kits and the 3-in-1 pills introduced by Cipla will promote adherence and ease of use. Viraday is the most remarkable accomplishment of Cipla.

Cipla has brought down the price of HIV/AIDS drugs in international market. It supplies HIV/AIDS drugs to majority of African, South Asian, Latin American and several other developing countries.

Source-Medindia
GYT

Find Viraday available at www.aids-drugs-online.com

Tuesday, February 20, 2007

HIV Funding announcement

Lewis confident in HIV vaccine funding announcement


Billionaire philanthropist Bill Gates and Prime Minister Stephen Harper are expected to announce joint financing plans on Tuesday to test a possible vaccine for HIV.

It is expected that the vaccine funding announcement will be made in Ottawa when Gates visits the Canadian Chamber of Commerce.

'This is an important step forward.'—Former UN Envoy for HIV/AIDS Stephen Lewis on expected HIV vaccine funding announcement

"Gates doesn't put a significant amount of money into vaccine research unless he's absolutely certain that it might yield something down the road," Stephen Lewis, the former UN secretary-general's special envoy for HIV/AIDS in Africa, told CBC Newsworld on Monday.

"They are scrupulous, the Bill Gates Foundation, in their assessment of what will work and what will not work. So this is an important step forward, and I honour the government of Canada for being a part of it."

Both the previous Liberal government and the current Conservative government have helped to fund the International AIDS Vaccine Initiative.

In an exclusive interview with Peter Mansbridge, chief correspondent of CBC News, Gates said he also anticipates a vaccine for HIV in his lifetime.

"This money is going to be spent on some very important causes in this century, and of the top 20 diseases that create the inequity, we will have either had drugs or vaccines to virtually eliminate most all of those," Gates said on Feb. 9. "AIDS is the toughest, but certainly in my lifetime, I'd be very surprised if we don't have a vaccine."

Tuesday's appearance will be another chance for the Prime Minister to address the AIDS issue. Last summer, Harper was criticized for not attending the International AIDS Conference in Toronto, where frontline workers, heads of state and scientists talked about issues including the search for a vaccine, the stigma around HIV and AIDS and circumcision as a form of prevention.

There was speculation that Harper would use the conference to announce new AIDS funding, but he said it wouldn't be the right time to make announcements because the issue had become "so politicized" during the week. Three cabinet ministers, including Health Minister Tony Clement attended the conference, along with Gov. Gen. Michaƫlle Jean.

The federal government has yet to demonstrate that it is willing to fight HIV on other fronts, such as funding the developing of an anti-retroviral drug to export to developing countries — an idea that has been on the books for four years, Lewis said.

It is important to fund all aspects of research: from antiretroviral treatment to keep people alive, to the search for microbicides to help protect women, to a vaccine, he added.

Microbicide setback

In one area of research hoped fight HIV/AIDS, scientists are developing vaginal microbicides, which are aimed at preventing sexual transmission of HIV and other sexually transmitted infections when applied topically. Scientists hope that women could be encouraged to apply them without their partner's knowledge, to reduce the risk of infection when men refuse to wear condoms.

However, in January, researchers halted studies in Africa and India of a microbicide developed in Canada after women using the gel showed a higher risk of infection rather than lower.

A microbicide likely won't be available for use for at least five years, and a vaccine 10 years, Lewis said, because HIV is so artful at outwitting scientific efforts.

The halted trial was a setback, but three other microbicide products are being tested in trials and others are in the pipeline, he said.